Italia markets open in 7 hours 46 minutes

GILD May 2024 72.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0300-0,2200 (-88,00%)
In data: 03:40PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,2500
Aperto0,0600
Denaro0,0000
Lettera0,0500
Prezzo d'esercizio72,50
Scadenza2024-05-17
Min-Max giorno0,0200 - 0,0600
Contratto - Min-MaxN/D
Volume22
Open Interest1,83k
  • GlobeNewswire

    Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

    PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic

  • GlobeNewswire

    Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

    LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq: GILD) as part of Gilead’s Relink grant program. CDA Foundation will disperse the grant to qualifying tax-exempt organizations to contact diagnosed but untreated patients with hepatitis C virus (HCV) or hepatitis B virus (HBV) infection to bring them back into care. Despite the availability of existing tr